Back to News & Events

The data dearth hampering heart failure care
08 May 2017

Despite affecting 15 million people across the EU, heart failure is poorly understood, partly because we are not collecting adequate data.

Read More
The Heart Failure Policy Network is made possible with financial support from Novartis Pharma, AstraZeneca and Vifor Pharma. The content produced by the Network is non-promotional and not biased to any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members.